Title:
EBV及びKHSV感染並びにそれに伴う異常細胞増殖の治療
Document Type and Number:
Japanese Patent JP2005528334
Kind Code:
A
Abstract:
A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.
More Like This:
| WO/1996/034859 | PROCESS FOR PREPARING SUBSTITUTED ARYLURACILS |
| WO/1996/019478 | 6'-SUBSTITUTED CARBOCYCLIC NUCLEOSIDES |
Inventors:
Sinaji, Raymond F
Ji Jin Shin
Joygarth, Joyce Day
Gustavson, Eritsk
Ji Jin Shin
Joygarth, Joyce Day
Gustavson, Eritsk
Application Number:
JP2003554120A
Publication Date:
September 22, 2005
Filing Date:
December 19, 2002
Export Citation:
Assignee:
Farm Set Limited
Beth Israel Deacones Medical Center
Emory University
Beth Israel Deacones Medical Center
Emory University
International Classes:
C07D239/54; A61K31/513; A61K31/58; A61K31/7072; A61K38/16; A61K45/06; A61K48/00; A61P31/12; A61P35/00; A61P43/00; C07D405/04; C07D405/14; C07D409/14; C07H19/067; C07H19/073; C07J43/00; (IPC1-7): A61K31/7072; A61K31/513; A61K48/00; A61P31/12; A61P35/00; A61P43/00
Domestic Patent References:
| JPS554364A | 1980-01-12 | |||
| JPS58213797A | 1983-12-12 | |||
| JPH01501551A | 1989-06-01 | |||
| JPH09508394A | 1997-08-26 | |||
| JP2001504468A | 2001-04-03 |
Foreign References:
| WO1999005158A1 | 1999-02-04 | |||
| WO1999005157A1 | 1999-02-04 | |||
| WO1999016447A1 | 1999-04-08 | |||
| WO2001006986A2 | 2001-02-01 |
Attorney, Agent or Firm:
Yoshio Kawaguchi
Akio Ichiiri
Makoto Ono
Katsuma Osaki
Mitsuaki Tsubokura
Akio Ichiiri
Makoto Ono
Katsuma Osaki
Mitsuaki Tsubokura